ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

JSPRW Jasper Therapeutics Inc

0.164
-0.036 (-18.00%)
29 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -12.71M-13.75M-13.95M-17.83M-19.36M-17.73M-15.07M-15.99M
Pre Tax Income -11.86M-13.21M-14.26M-16.08M-17.54M-16.58M-13.73M-14.58M
Net Income -11.86M-13.21M-14.26M-16.08M-17.54M-16.58M-13.73M-14.58M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -7.09M-18.8M-14.78M-17.52M-18.98M-17.82M-15.11M-16.03M
EBITDA -12.44M-13.47M-13.67M-17.55M-19.09M-17.44M-14.78M-15.69M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -136k-935k-36.83M-51.2M-68.86M
Pre Tax Income 18k-552k-30.64M-37.69M-64.47M
Net Income 2k-591k-30.64M-37.69M-64.47M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) 0-0.091-0.685-0.839-0.544
EBIT -136k-935k-36.91M-50.61M-69.09M
EBITDA -136k-935k-36.46M-50.22M-67.75M